Teva Pharmaceutical Industries (TEVA) Net Margin Growth (5y) (2021 - 2026)

Teva Pharmaceutical Industries (TEVA) Net Margin Growth (5y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3,162.00
Dec 31, 2025 652.00
Sep 30, 2025 11,888.00
Jun 30, 2025 294.00
Mar 31, 2025 389.00
Dec 31, 2024 -1,219.00
Sep 30, 2024 -876.00
Jun 30, 2024 -944.00
Mar 31, 2024 918.00
Dec 31, 2023 6,308.00
Sep 30, 2023 -692.00
Jun 30, 2023 -3,501.00
Mar 31, 2023 -4,888.00
Dec 31, 2022 16,011.00
Sep 30, 2022 -2,855.00
Jun 30, 2022 7,727.00
Mar 31, 2022 -6,186.00
Dec 31, 2021 -7,946.00